TPG Group Holdings (SBS) Advisors’s Flexion Therapeutics, Inc. FLXN Stock Holding History

TPG Group Holdings (SBS) Advisors’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$5.71M	Hold	936,507	–	–	0.06%	41
2021 Q2	$7.71M	Hold	936,507	–	–	0.05%	46
2021 Q1	$8.38M	Hold	936,507	–	–	0.1%	45
2020 Q4	$10.8M	Hold	936,507	–	–	0.12%	35
2020 Q3	$9.75M	Hold	936,507	–	–	0.17%	36
2020 Q2	$12.3M	Hold	936,507	–	–	0.22%	33
2020 Q1	$7.37M	Hold	936,507	–	–	0.17%	32
2019 Q4	$19.4M	Hold	936,507	–	–	0.29%	33
2019 Q3	$12.8M	Hold	936,507	–	–	0.19%	41
2019 Q2	$11.5M	Hold	936,507	–	–	0.17%	41
2019 Q1	$11.7M	Hold	936,507	–	–	0.23%	41
2018 Q4	$10.6M	Hold	936,507	–	–	0.17%	45
2018 Q3	$17.5M	Hold	936,507	–	–	0.22%	46
2018 Q2	$24.2M	Hold	936,507	–	–	0.32%	39
2018 Q1	$21M	Hold	936,507	–	–	0.32%	32
2017 Q4	$23.4M	Hold	936,507	–	–	0.36%	30
2017 Q3	$22.6M	Hold	936,507	–	–	0.37%	31
2017 Q2	$18.9M	Hold	936,507	–	–	0.26%	34
2017 Q1	$25.2M	Hold	936,507	–	–	0.3%	38
2016 Q4	$17.8M	Buy	936,507 +222,222	+31%	+$4.25M	0.19%	41
2016 Q3	$14M	Hold	714,285	–	–	0.14%	44
2016 Q2	$10.7M	Buy	+714,285	New	+$8.98M	0.12%	45

Other funds holding FLXN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TPG Group Holdings (SBS) Advisors's FLXN Position: Q3 2021 in Review

TPG Group Holdings (SBS) Advisors held its Flexion Therapeutics, Inc. (FLXN) position steady in Q3 2021 at 936,507 shares worth $5.71M. The position accounts for 0.06% of the portfolio, ranked #41.

TPG Group Holdings (SBS) Advisors first reported a position in FLXN in Q2 2016 and has held it in 22 quarters since. The position peaked at $25.2M in Q1 2017. 145 funds tracked by Wall St. Rank hold FLXN as of Q3 2021.

TPG Group Holdings (SBS) Advisors held 936,507 shares of Flexion Therapeutics, Inc. worth $5.71M as of Q3 2021.
TPG Group Holdings (SBS) Advisors left its Flexion Therapeutics, Inc. share count unchanged in Q3 2021.
Flexion Therapeutics, Inc. made up 0.06% of TPG Group Holdings (SBS) Advisors's portfolio in Q3 2021, its #41 holding.
TPG Group Holdings (SBS) Advisors first reported a position in Flexion Therapeutics, Inc. in Q2 2016 and has held it in 22 quarters since.
TPG Group Holdings (SBS) Advisors's Flexion Therapeutics, Inc. position peaked at $25.2M in Q1 2017.
145 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2021.

Based on TPG Group Holdings (SBS) Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.